Chronic ethanol potentiates the effect of neuropeptide s in the basolateral amygdala and shows increased anxiolytic and anti-depressive effects

Neuropsychopharmacology

Volumn 37, Issue 11, 2012, Pages 2436-2445

  Enquist, Johan ^a   Ferwerda, Madeline ^a   Madhavan, Anuradha ^a   Hok, Derek ^a   Whistler, Jennifer L ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

alcohol; anxiety; depression; NPSR; reward

Indexed keywords

ALCOHOL; NEUROPEPTIDE S;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; REWARD; TASK PERFORMANCE; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME;

ADAPTATION, OCULAR; AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY; CONDITIONING, OPERANT; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; DRUG SYNERGISM; ETHANOL; HINDLIMB SUSPENSION; MALE; MAZE LEARNING; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; NEUROPEPTIDES; PATCH-CLAMP TECHNIQUES; SWIMMING; TIME FACTORS;

EID: 84866363783     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.102     Document Type: Article

References (41)

1. Badia-Elder NE, Henderson AN, Bertholomey ML, Dodge NC, Stewart RB (2008). The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and-nonpreferring rats. Alcohol Clin Exp Res 32: 1380-1387.
2. Berger AC, Whistler JL (2011). Morphine-induced mu opioid receptor trafficking enhances reward yet prevents compulsive drug use. EMBO Mol Med 7: 385-397.
3. Breese GR, Chu K, Dayas CV, Funk D, Knapp DJ, Koob GF et al (2005). Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res 29: 185-195. (Pubitemid 40250507)
4. Cannella N, Economidou D, Kallupi M, Stopponi S, Heilig M, Massi M et al (2009). Persistent increase of alcoholseeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 34: 2125-2134.
5. Cao J, de Lecea L, Ikemoto S (2011). Intraventricular administration of neuropeptide S has reward-like effects. Eur J Pharmacol 658: 16-21.
6. Cifani C, Di Bonaventura MV, Cannella N, Fedeli A, Guerrini R, Calo G et al (2011). Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat. Peptides 32: 44-50.
7. Dannlowski U, Kugel H, Franke F, Stuhrmann A, Hohoff C, Zwanzger P et al (2011). Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacology 36: 1879-1885.
8. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P et al (2011). Neuropeptide S receptor geneFconverging evidence for a role in panic disorder. Mol Psychiatry 9: 938-948.
9. Duangdao DM, Clark SD, Okamura N, Reinscheid RK (2009). Behavioral phenotyping of neuropeptide S receptor knockout mice. Behav Brain Res 205: 1-9.
10. Funk CK, O'Dell LE, Crawford EF, Koob GF (2006). Corticotropinreleasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 26: 11324-11332. (Pubitemid 44772162)
11. Isbister GK, O'Regan L, Sibbritt D, Whyte IM (2004). Alprazolam is relatively more toxic than other benzodiazepines in overdose. Br J Clin Pharmacol 58: 88-95. (Pubitemid 38901472)
12. Jungling K, Seidenbecher T, Sosulina L, Lesting J, Sangha S, Clark SD et al (2008). Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 59: 298-310. (Pubitemid 352033690)
13. Koob GF (2000). Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci 909: 170-185. (Pubitemid 30462039)
14. Lack AK, Diaz MR, Chappell A, DuBois DW, McCool BA (2007). Chronic ethanol and withdrawal differentially modulate pre-and postsynaptic function at glutamatergic synapses in rat basolateral amygdala. J Neurophysiol 98: 3185-3196.
15. Li W, Gao YH, Chang M, Peng YL, Yao J, Han RW et al (2009). Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice. Peptides 30: 234-240.
16. Little HJ, O'Callaghan MJ, Butterworth AR, Wilson J, Cole J, Watson WP (1999). Low alcohol preference among the 'high alcohol preference' C57 strain of mice; preference increased by saline injections. Psychopharmacology (Berl) 147: 182-189. (Pubitemid 30010566)
17. McKay PF, Foster KL, Mason D, Cummings R, Garcia M, Williams LS et al (2004). A high affinity ligand for GABAA-receptor containing alpha5 subunit antagonizes ethanol's neurobehavioral effects in Long-Evans rats. Psychopharmacology (Berl) 172: 455-462. (Pubitemid 38650983)
18. Meis S, Bergado-Acosta JR, Yanagawa Y, Obata K, Stork O, Munsch T (2008). Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS One 3: e2695.
19. Niimi M (2006). Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats. Endocrine 30: 75-79. (Pubitemid 46020333)
20. Nunes EV, Levin FR (2004). Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 291: 1887-1896. (Pubitemid 38509503)
21. O'Brien C P (2005). Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66(Suppl 2): 28-33. (Pubitemid 40343678)
22. Pandey SC, Roy A, Zhang H (2003). The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Alcohol Clin Exp Res 27: 396-409. (Pubitemid 36343284)
23. Paneda C, Huitron-Resendiz S, Frago LM, Chowen JA, Picetti R, de Lecea L et al (2009). Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice. J Neurosci 29: 4155-4161.
24. Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993). Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605: 25-32. (Pubitemid 23083057)
25. Reinscheid RK (2008). Neuropeptide S: anatomy, pharmacology, genetics and physiological functions. Results Probl Cell Differ 46: 145-158.
26. Richardson HN, Lee SY, O'Dell LE, Koob GF, Rivier CL (2008). Alcohol self-administration acutely stimulates the hypothalamicpituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci 28: 1641-1653.
27. Rose AK, Shaw SG, Prendergast MA, Little HJ (2010). The importance of glucocorticoids in alcohol dependence and neurotoxicity. Alcohol Clin Exp Res 34: 2011-2018.
28. Ruggeri B, Braconi S, Cannella N, Kallupi M, Soverchia L, Ciccocioppo R et al (2010). Neuropeptide S receptor gene expression in alcohol withdrawal and protracted abstinence in postdependent rats. Alcohol Clin Exp Res 34: 90-97.
29. Schmitt U, Waldhofer S, Weigelt T, Hiemke C (2002). Free-choice ethanol consumption under the influence of GABAergic drugs in rats. Alcohol Clin Exp Res 26: 457-462. (Pubitemid 34408710)
30. Sheline YI, Gado MH, Price JL (1998). Amygdala core nuclei volumes are decreased in recurrent major depression. Neuro Report 9: 2023-2028. (Pubitemid 28300560)
31. Sinha R (2001). How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 158: 343-359. (Pubitemid 33141310)
32. Soderpalm AH, Hansen S (1998). Benzodiazepines enhance the consumption and palatability of alcohol in the rat. Psychopharmacology (Berl) 137: 215-222. (Pubitemid 28277506)
33. Steru L, Chermat R, Thierry B, Simon P (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367-370. (Pubitemid 15123115)
34. Sunal R, Gumusel B, Kayaalp SO (1994). Effect of changes in swimming area on results of 'behavioral despair test'. Pharmacol Biochem Behav 49: 891-896.
35. Tye KM, Prakash R, Kim SY, Fenno LE, Grosenick L, Zarabi H et al (2011). Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 471: 358-362.
36. van Rijn RM, Brissett DI, Whistler JL (2010). Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety. J Pharmacol Exp Ther 335: 133-139.
37. Walker BM, Drimmer DA, Walker JL, Liu T, Mathe AA, Ehlers CL (2010). Effects of prolonged ethanol vapor exposure on forced swim behavior, and neuropeptide Y and corticotropin-releasing factor levels in rat brains. Alcohol 44: 487-493.
38. Williams HL, Rundell Jr OH (1981). Altered sleep physiology in chronic alcoholics: reversal with abstinence. Alcohol Clin Exp Res 5: 318-325. (Pubitemid 11116977)
39. Xu YL, Gall CM, Jackson VR, Civelli O, Reinscheid RK (2007). Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500: 84-102. (Pubitemid 44904303)
40. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH et al (2004). Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43: 487-497. (Pubitemid 39094676)
41. Zhu H, Mingler MK, McBride ML, Murphy AJ, Valenzuela DM, Yancopoulos GD et al (2010). Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1. Psychoneuroendocrinology 35: 1119-1132.